据贝哲斯咨询发布的2024版健康测试市场分析报告，全球和中国健康测试市场规模在2023年分别达到 亿元（人民币）与 亿元。报告结合健康测试行业发展环境和市场动态，对未来几年内健康测试市场做出了合理预测。报告预计至2029年全球健康测试市场规模将会达到 ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...

Citi upgraded Charles River Laboratories (NYSE:CRL) and LabCorp (NYSE:LH) while downgrading Quest Diagnostics (NYSE:DGX), ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Quest Diagnostics plans to buy select assets of Fresenius Medical Care’s laboratory testing services business Spectra Laboratories for an undisclosed amount. The sale fits in with Fresenius ...

Competitive Landscape: Quest Diagnostics faces intense competition, primarily from LabCorp, other commercial laboratories and hospitals. While pricing is an important factor in choosing a testing ...

Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight ...

Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME’s wholly owned Spectra Laboratories ...